INVESTIGATION OF THE ELIMINATION OF DABIGATRAN BY HAEMODIALYSIS IN PATIENTS WITH END STAGE RENAL DISEASE (ESRD)

被引:0
|
作者
Haertter, S. [1 ]
Trenmmel, M. [1 ]
Nehmiz, G. [4 ]
Liesenfeld, K. [1 ]
Moschetti, V. [1 ]
Peters, H. [2 ]
Wagner, F. [3 ]
Formella, S. [5 ]
机构
[1] Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med, Ingelheim, Germany
[2] Charite, Dept Nephrol, Berlin, Germany
[3] Charite Res Org, Berlin, Germany
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
[5] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:S32 / S32
页数:1
相关论文
共 50 条
  • [41] TRENDS IN ANEMIA MANAGEMENT FOR END STAGE RENAL DISEASE (ESRD) PATIENTS ON DIALYSIS
    Wish, Jay
    Hariri, Ali
    Harrison, Will
    Yang, Alex
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (04) : A90 - A90
  • [42] The nature of impairments of memory in patients with end-stage renal disease (ESRD)
    Jones, Daniel J. W.
    Harris, John P.
    Vaux, Emma
    Hadid, Rebecca
    Kean, Rebecca
    Butler, Laurie T.
    PHYSIOLOGY & BEHAVIOR, 2015, 147 : 324 - 333
  • [43] Sevelamer HCL(RENAGEL®) in paediatric patients with end stage renal disease(ESRD)
    Gaydarova, MS
    Anadoliyski, KA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V94 - V95
  • [44] ANXIETY, DEPRESSION AND HEALTH BELIEFS IN END STAGE RENAL DISEASE (ESRD) PATIENTS
    Karamanidou, C.
    Theofilou, P.
    Ginieri-Coccossis, M.
    Synodinou, C.
    Papadimitriou, G.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [45] Vitamin D status of patients with end-stage renal disease (ESRD).
    Nagrecha, N
    Ulrich, T
    Zasuwa, G
    Gupta, A
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S423 - S423
  • [46] Cohort review of patients with parathyroid cancer in End Stage Renal Disease (ESRD)
    Victoria Zheng
    James Lee
    Rajeev Parameswaran
    Langenbeck's Archives of Surgery, 409 (1)
  • [47] LIPOPROTEIN (A) [LP(A)] IN PATIENTS WITH END-STAGE RENAL-DISEASE (ESRD)
    KOCH, M
    BOLLMANN, S
    KUTKUHN, B
    GRABENSEE, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 543 - 543
  • [48] PHARMACOKINETICS OF ZIDOVUDINE (AZT) IN PATIENTS WITH END STAGE RENAL-DISEASE (ESRD)
    LEW, SQ
    KIMMEL, PL
    LI, PP
    STRAW, J
    BOSCH, JP
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 307 - 307
  • [49] END-STAGE RENAL-DISEASE (ESRD) IN PATIENTS WITH EATING DISORDERS
    ABDELRAHMAN, EM
    MOORTHY, AV
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 410 - 410
  • [50] Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease (ESRD)
    Zoccali, Carmine
    Benedetto, Francesco A.
    Mallamaci, Francesca
    Tripepi, Giovanni
    Cutrupi, Sebastiano
    Pizzini, Patrizia
    Malatino, Lorenzo S.
    Bonanno, Graziella
    Seminara, Giuseppe
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 297 - 297